MedPath

KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTER

🇸🇦Saudi Arabia
Ownership
-
Employees
-
Market Cap
-
Website

Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

Not Applicable
Completed
Conditions
Transitional Carcinoma of Urinary Bladder
First Posted Date
2007-10-05
Last Posted Date
2015-12-17
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
10
Registration Number
NCT00539773

Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

Phase 3
Suspended
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
Radiation: Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin
First Posted Date
2007-10-05
Last Posted Date
2011-03-08
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
10
Registration Number
NCT00540280

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Not Applicable
Completed
Conditions
Colonic Neoplasms
Rectal Neoplasms
First Posted Date
2007-10-02
Last Posted Date
2015-12-17
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
100
Registration Number
NCT00537901

Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Drug: Doxorubicin, Docetaxel, Cisplatin
First Posted Date
2007-10-02
Last Posted Date
2012-05-30
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
10
Registration Number
NCT00538525

Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

Not Applicable
Conditions
Breast Cancer
First Posted Date
2007-10-02
Last Posted Date
2011-12-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
2000
Registration Number
NCT00538330

Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer

Not Applicable
Conditions
Breast Cancer
First Posted Date
2007-10-02
Last Posted Date
2011-12-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
100
Registration Number
NCT00538395

Prospective Database for Acute Myeloblastic Leukemia

Not Applicable
Conditions
Leukemia, Myeloblastic, Acute
First Posted Date
2007-10-02
Last Posted Date
2011-12-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
2000
Registration Number
NCT00538278

Prospective Database for Chronic Myelogenous Leukemia

Not Applicable
Conditions
Leukemia, Myeloid, Chronic
First Posted Date
2007-10-02
Last Posted Date
2011-12-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
2000
Registration Number
NCT00538447
© Copyright 2025. All Rights Reserved by MedPath